137 related articles for article (PubMed ID: 17434898)
1. Up-to-date survival estimates and historical trends of cutaneous malignant melanoma in the south-east of The Netherlands.
de Vries E; Houterman S; Janssen-Heijnen ML; Nijsten T; van de Schans SA; Eggermont AM; Coebergh JW
Ann Oncol; 2007 Jun; 18(6):1110-6. PubMed ID: 17434898
[TBL] [Abstract][Full Text] [Related]
2. Trends of cutaneous melanoma in The Netherlands: increasing incidence rates among all Breslow thickness categories and rising mortality rates since 1989.
Hollestein LM; van den Akker SA; Nijsten T; Karim-Kos HE; Coebergh JW; de Vries E
Ann Oncol; 2012 Feb; 23(2):524-30. PubMed ID: 21543630
[TBL] [Abstract][Full Text] [Related]
3. Population-based 20-year survival among people diagnosed with thin melanomas in Queensland, Australia.
Green AC; Baade P; Coory M; Aitken JF; Smithers M
J Clin Oncol; 2012 May; 30(13):1462-7. PubMed ID: 22412152
[TBL] [Abstract][Full Text] [Related]
4. Survival of cutaneous melanoma based on sex, age, and stage in the United States, 1992-2011.
Enninga EAL; Moser JC; Weaver AL; Markovic SN; Brewer JD; Leontovich AA; Hieken TJ; Shuster L; Kottschade LA; Olariu A; Mansfield AS; Dronca RS
Cancer Med; 2017 Oct; 6(10):2203-2212. PubMed ID: 28879661
[TBL] [Abstract][Full Text] [Related]
5. Conditional survival of malignant melanoma in The Netherlands: 1994-2008.
van der Leest RJ; van Steenbergen LN; Hollestein LM; de Vries E; Nijsten T; van Akkooi AC; Janssen-Heijnen ML; Coebergh JW
Eur J Cancer; 2014 Feb; 50(3):602-10. PubMed ID: 24262585
[TBL] [Abstract][Full Text] [Related]
6. Invasive cutaneous malignant melanoma in Sweden, 1990-1999. A prospective, population-based study of survival and prognostic factors.
Lindholm C; Andersson R; Dufmats M; Hansson J; Ingvar C; Möller T; Sjödin H; Stierner U; Wagenius G;
Cancer; 2004 Nov; 101(9):2067-78. PubMed ID: 15372475
[TBL] [Abstract][Full Text] [Related]
7. Improved survival for melanoma in Northern Ireland: a comparison of two 5-year periods (1984-88 and 1994-98).
McMullen EA; Kee F; Patterson CC; Gavin AT; Dolan OM
Br J Dermatol; 2004 Sep; 151(3):587-93. PubMed ID: 15377344
[TBL] [Abstract][Full Text] [Related]
8. The incidence and mortality of cutaneous melanoma in Southern Germany: trends by anatomic site and pathologic characteristics, 1976 to 2003.
Lasithiotakis KG; Leiter U; Gorkievicz R; Eigentler T; Breuninger H; Metzler G; Strobel W; Garbe C
Cancer; 2006 Sep; 107(6):1331-9. PubMed ID: 16909413
[TBL] [Abstract][Full Text] [Related]
9. Increasing time trends of thin melanomas in The Netherlands: What are the explanations of recent accelerations?
van der Leest RJ; Zoutendijk J; Nijsten T; Mooi WJ; van der Rhee JI; de Vries E; Hollestein LM
Eur J Cancer; 2015 Dec; 51(18):2833-41. PubMed ID: 26589973
[TBL] [Abstract][Full Text] [Related]
10. Incidence trends and clinical-pathological characteristics of invasive cutaneous melanoma from 1980 to 2010 in the Canton of Zurich, Switzerland.
Minini R; Rohrmann S; Braun R; Korol D; Dehler S
Melanoma Res; 2017 Apr; 27(2):145-151. PubMed ID: 27926588
[TBL] [Abstract][Full Text] [Related]
11. Epidemiology of malignant melanoma in central Europe: risk factors and prognostic predictors. Results of the Central Malignant Melanoma Registry of the German Dermatological Society.
Garbe C; Orfanos CE
Pigment Cell Res; 1992; Suppl 2():285-94. PubMed ID: 1409431
[TBL] [Abstract][Full Text] [Related]
12. Prognostic factors for cutaneous malignant melanoma in Vaud, Switzerland.
Levi F; Randimbison L; La Vecchia C; Te VC; Franceschi S
Int J Cancer; 1998 Oct; 78(3):315-9. PubMed ID: 9766565
[TBL] [Abstract][Full Text] [Related]
13. Population-based incidence and melanoma-specific survival of cutaneous malignant melanoma in a Colombian population 2000-2009.
Reyes E; Uribe C; de Vries E
Int J Dermatol; 2018 Jan; 57(1):21-27. PubMed ID: 29231241
[TBL] [Abstract][Full Text] [Related]
14. Prognosis for patients with thin cutaneous melanoma: long-term survival data from New South Wales Central Cancer Registry and the Sydney Melanoma Unit.
McKinnon JG; Yu XQ; McCarthy WH; Thompson JF
Cancer; 2003 Sep; 98(6):1223-31. PubMed ID: 12973846
[TBL] [Abstract][Full Text] [Related]
15. A population-based study of cutaneous melanoma in Alberta, Canada (1993-2002).
Metelitsa AI; Dover DC; Smylie M; de Gara CJ; Lauzon GJ
J Am Acad Dermatol; 2010 Feb; 62(2):227-32. PubMed ID: 20018405
[TBL] [Abstract][Full Text] [Related]
16. Melanoma in older patients: declining gap in survival between younger and older patients with melanoma.
Schuurman MS; Hollestein LM; Bastiaannet E; Posthuma EFM; van Akkooi AJC; Kukutsch NA; Aarts MJB; Wakkee M; Lemmens VEPP; Louwman MWJ
Acta Oncol; 2020 Jan; 59(1):4-12. PubMed ID: 31347929
[No Abstract] [Full Text] [Related]
17. Cutaneous malignant melanoma in Scotland: incidence, survival, and mortality, 1979-94. The Scottish Melanoma Group.
MacKie RM; Hole D; Hunter JA; Rankin R; Evans A; McLaren K; Fallowfield M; Hutcheon A; Morris A
BMJ; 1997 Nov; 315(7116):1117-21. PubMed ID: 9374883
[TBL] [Abstract][Full Text] [Related]
18. Development of prognostic factors and survival in cutaneous melanoma over 25 years: An analysis of the Central Malignant Melanoma Registry of the German Dermatological Society.
Buettner PG; Leiter U; Eigentler TK; Garbe C
Cancer; 2005 Feb; 103(3):616-24. PubMed ID: 15630700
[TBL] [Abstract][Full Text] [Related]
19. Trends in prognostic factors and survival from cutaneous melanoma in Yorkshire, UK and New South Wales, Australia between 1993 and 2003.
Downing A; Yu XQ; Newton-Bishop J; Forman D
Int J Cancer; 2008 Aug; 123(4):861-6. PubMed ID: 18500743
[TBL] [Abstract][Full Text] [Related]
20. Clinical and histopathologic predictors of survival in patients with malignant melanoma: a population-based study in Sweden.
Thörn M; Pontén F; Bergström R; Sparén P; Adami HO
J Natl Cancer Inst; 1994 May; 86(10):761-9. PubMed ID: 8169974
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
